Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WestVac XBB.1.5 Booster Vaccine Phase 3 Study
NCT06175494Phase 3Recruiting
- Sponsor
- WestVac Biopharma
- Start
- Dec 2023
- Primary completion
- Jul 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant COVID-19 (XBB) trimer protein vaccine in coronavirus disease 2019 (COVID-19), sponsored by WestVac Biopharma. Started Dec 2023; status: recruiting.
02
Drugs
recombinant COVID-19 (XBB) trimer protein vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT06175494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06175494.